Wells Fargo & Company MN cut its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 10.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,081,282 shares of the pharmacy operator's stock after selling 128,218 shares during the period. Wells Fargo & Company MN owned about 0.13% of Walgreens Boots Alliance worth $10,088,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also modified their holdings of WBA. Brooklyn Investment Group increased its holdings in shares of Walgreens Boots Alliance by 21.1% during the fourth quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator's stock worth $44,000 after buying an additional 830 shares in the last quarter. First Financial Corp IN increased its holdings in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock valued at $25,000 after purchasing an additional 885 shares in the last quarter. CWA Asset Management Group LLC raised its position in Walgreens Boots Alliance by 9.2% in the 4th quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator's stock valued at $120,000 after purchasing an additional 1,084 shares during the last quarter. Metis Global Partners LLC grew its holdings in shares of Walgreens Boots Alliance by 4.9% during the fourth quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator's stock worth $222,000 after purchasing an additional 1,118 shares during the last quarter. Finally, Harbour Investments Inc. increased its stake in shares of Walgreens Boots Alliance by 4.3% in the fourth quarter. Harbour Investments Inc. now owns 28,389 shares of the pharmacy operator's stock valued at $265,000 after buying an additional 1,165 shares in the last quarter. Institutional investors own 58.59% of the company's stock.
Analysts Set New Price Targets
Several research analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and reduced their price target for the stock from $11.00 to $9.00 in a research report on Friday, February 28th. Evercore ISI increased their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a research note on Monday, January 13th. Royal Bank of Canada raised their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a report on Wednesday, January 15th. Truist Financial reduced their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, January 31st. Finally, Bank of America lifted their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research note on Monday, January 13th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of "Hold" and a consensus price target of $10.59.
Check Out Our Latest Stock Analysis on Walgreens Boots Alliance
Walgreens Boots Alliance Trading Up 1.1 %
NASDAQ:WBA traded up $0.12 during mid-day trading on Tuesday, hitting $10.99. The company had a trading volume of 10,775,459 shares, compared to its average volume of 21,036,217. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $18.83. The firm has a market cap of $9.50 billion, a P/E ratio of -1.07, a P/E/G ratio of 1.31 and a beta of 0.67. The business's fifty day moving average is $10.90 and its two-hundred day moving average is $10.17.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, beating analysts' consensus estimates of $0.53 by $0.10. The business had revenue of $38.59 billion for the quarter, compared to the consensus estimate of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. Walgreens Boots Alliance's revenue for the quarter was up 4.1% on a year-over-year basis. During the same period last year, the company posted $1.20 EPS. As a group, research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.
About Walgreens Boots Alliance
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Articles

Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.